How a ‘one and done’ gene-editing treatment could lower cholesterol

A cutting-edge medical experiment in a small trial has demonstrated the effectiveness of a one-time CRISPR gene editing treatment in lowering cholesterol levels 

View original article
Contributor: Carolyn Y. Johnson